Ligand validation:6WMV

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6WMV_OLC_C_307	51%	54%	0.145	0.899	0.94	0.85	1	1	2	0	100%	1
6WMV_OLC_A_308	34%	40%	0.154	0.932	1.36	0.99	1	1	0	0	48%	0.48
6WMV_OLC_A_307	27%	49%	0.186	0.856	1.04	0.92	1	1	1	0	88%	0.88
6WMV_OLC_C_308	24%	41%	0.161	0.875	1.32	0.99	1	1	1	0	52%	0.52
6WMV_OLC_A_309	23%	29%	0.15	0.88	1.5	1.33	1	1	0	0	40%	0.4
6WMV_OLC_C_306	10%	38%	0.157	0.765	1.44	1	1	1	0	0	44%	0.44
6WMV_OLC_C_305	9%	36%	0.154	0.728	1.4	1.13	1	1	0	0	48%	0.48
6WM5_OLC_C_308	45%	51%	0.142	0.873	0.96	0.92	1	2	4	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.